US Stock MarketDetailed Quotes

CTNM Contineum Therapeutics

Watchlist

18.805
-0.245-1.29%

Trading Jun 20 14:46 ET

483.73MMarket Cap-145775P/E (TTM)

Contineum Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-52.08%-7.98M

196.16%19.35M

-162.61%-10.7M

-5.24M

23.40%-20.12M

-4.08M

-26.27M

Net income from continuing operations

-74.48%-8.42M

193.68%22.72M

-3.42%-7.77M

---4.82M

16.37%-24.25M

---7.51M

---29M

Operating gains losses

387.50%117K

300.00%14K

-100.00%-6K

--24K

-250.00%-7K

---3K

---2K

Depreciation and amortization

-16.44%61K

-40.73%195K

-54.32%37K

--73K

1.23%329K

--81K

--325K

Other non cash items

-7.58%244K

-172.46%-2.1M

-89.73%263K

--264K

1,667.07%2.9M

--2.56M

--164K

Change In working capital

127.12%275K

19.18%-1.02M

-765.87%-2.79M

---1.01M

-1,273.15%-1.27M

--419K

--108K

-Change in prepaid assets

1,288.33%713K

-237.83%-1.28M

-131.17%-24K

---60K

-0.53%-378K

--77K

---376K

-Change in payables and accrued expense

35.34%-450K

2,244.12%1.59M

-450.63%-2.23M

---696K

-80.90%68K

--636K

--356K

-Change in other current assets

--0

121.88%7K

203.13%33K

--5K

-300.00%-32K

---32K

--16K

-Change in other current liabilities

104.56%12K

-45.73%-1.35M

-90.40%-1.35M

---263K

-925.89%-925K

---708K

--112K

Cash from discontinued investing activities

Operating cash flow

-52.08%-7.98M

196.16%19.35M

-162.55%-10.7M

---5.24M

23.40%-20.12M

---4.08M

---26.27M

Investing cash flow

Cash flow from continuing investing activities

-6.67%8.73M

-394.04%-65.57M

83.65%9.03M

9.36M

134.32%22.3M

4.92M

-64.97M

Net PPE purchase and sale

-182.69%-147K

-250.85%-414K

---309K

---52K

29.76%-118K

--0

---168K

Net investment purchase and sale

-5.62%8.88M

-390.65%-65.15M

89.93%9.34M

--9.41M

134.59%22.42M

--4.92M

---64.8M

Cash from discontinued investing activities

Investing cash flow

-6.67%8.73M

-394.04%-65.57M

83.65%9.03M

--9.36M

134.32%22.3M

--4.92M

---64.97M

Financing cash flow

Cash flow from continuing financing activities

97.08%-18K

4,633.98%56.18M

48.64%-321K

-617K

-101.55%-1.24M

-625K

79.84M

Net issuance payments of debt

--0

-200.00%-3.75M

--0

---625K

---1.25M

---625K

--0

Net common stock issuance

----

-600.00%-28K

--1K

----

---4K

--0

Net preferred stock issuance

----

--60.14M

--0

----

--0

--79.73M

Proceeds from stock option exercised by employees

1,425.00%122K

960.00%159K

--21K

--8K

-86.73%15K

--0

--113K

Net other financing activities

---140K

---343K

----

Cash from discontinued financing activities

Financing cash flow

97.08%-18K

4,633.98%56.18M

48.64%-321K

---617K

-101.55%-1.24M

---625K

--79.84M

Net cash flow

Beginning cash position

178.79%15.53M

20.28%5.57M

227.25%17.52M

--5.57M

-71.11%4.63M

--5.35M

--16.03M

Current changes in cash

-78.88%738K

960.38%9.96M

-1,027.91%-2M

--3.49M

108.24%939K

--215K

---11.4M

End cash Position

79.45%16.26M

178.79%15.53M

--9.06M

20.28%5.57M

--5.57M

--4.63M

Free cash flow

-53.36%-8.12M

193.56%18.94M

-170.13%-11.01M

---5.3M

23.44%-20.24M

---4.08M

---26.43M

Currency Unit

USD

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-52.08%-7.98M	196.16%19.35M	-162.61%-10.7M	-5.24M	23.40%-20.12M	-4.08M	-26.27M
Net income from continuing operations	-74.48%-8.42M	193.68%22.72M	-3.42%-7.77M	---4.82M	16.37%-24.25M	---7.51M	---29M
Operating gains losses	387.50%117K	300.00%14K	-100.00%-6K	--24K	-250.00%-7K	---3K	---2K
Depreciation and amortization	-16.44%61K	-40.73%195K	-54.32%37K	--73K	1.23%329K	--81K	--325K
Other non cash items	-7.58%244K	-172.46%-2.1M	-89.73%263K	--264K	1,667.07%2.9M	--2.56M	--164K
Change In working capital	127.12%275K	19.18%-1.02M	-765.87%-2.79M	---1.01M	-1,273.15%-1.27M	--419K	--108K
-Change in prepaid assets	1,288.33%713K	-237.83%-1.28M	-131.17%-24K	---60K	-0.53%-378K	--77K	---376K
-Change in payables and accrued expense	35.34%-450K	2,244.12%1.59M	-450.63%-2.23M	---696K	-80.90%68K	--636K	--356K
-Change in other current assets	--0	121.88%7K	203.13%33K	--5K	-300.00%-32K	---32K	--16K
-Change in other current liabilities	104.56%12K	-45.73%-1.35M	-90.40%-1.35M	---263K	-925.89%-925K	---708K	--112K
Cash from discontinued investing activities
Operating cash flow	-52.08%-7.98M	196.16%19.35M	-162.55%-10.7M	---5.24M	23.40%-20.12M	---4.08M	---26.27M
Investing cash flow
Cash flow from continuing investing activities	-6.67%8.73M	-394.04%-65.57M	83.65%9.03M	9.36M	134.32%22.3M	4.92M	-64.97M
Net PPE purchase and sale	-182.69%-147K	-250.85%-414K	---309K	---52K	29.76%-118K	--0	---168K
Net investment purchase and sale	-5.62%8.88M	-390.65%-65.15M	89.93%9.34M	--9.41M	134.59%22.42M	--4.92M	---64.8M
Cash from discontinued investing activities
Investing cash flow	-6.67%8.73M	-394.04%-65.57M	83.65%9.03M	--9.36M	134.32%22.3M	--4.92M	---64.97M
Financing cash flow
Cash flow from continuing financing activities	97.08%-18K	4,633.98%56.18M	48.64%-321K	-617K	-101.55%-1.24M	-625K	79.84M
Net issuance payments of debt	--0	-200.00%-3.75M	--0	---625K	---1.25M	---625K	--0
Net common stock issuance	----	-600.00%-28K	--1K	----	---4K	--0	--0
Net preferred stock issuance	----	--60.14M	--0	----	--0	--0	--79.73M
Proceeds from stock option exercised by employees	1,425.00%122K	960.00%159K	--21K	--8K	-86.73%15K	--0	--113K
Net other financing activities	---140K	---343K	----	----	----	----	----
Cash from discontinued financing activities
Financing cash flow	97.08%-18K	4,633.98%56.18M	48.64%-321K	---617K	-101.55%-1.24M	---625K	--79.84M
Net cash flow
Beginning cash position	178.79%15.53M	20.28%5.57M	227.25%17.52M	--5.57M	-71.11%4.63M	--5.35M	--16.03M
Current changes in cash	-78.88%738K	960.38%9.96M	-1,027.91%-2M	--3.49M	108.24%939K	--215K	---11.4M
End cash Position	79.45%16.26M	178.79%15.53M	178.79%15.53M	--9.06M	20.28%5.57M	--5.57M	--4.63M
Free cash flow	-53.36%-8.12M	193.56%18.94M	-170.13%-11.01M	---5.3M	23.44%-20.24M	---4.08M	---26.43M
Currency Unit	USD	USD	USD	USD	USD	USD	USD

Analysis

Analyst Rating

No Data

Price Target

No Data

Overall

Top Gainers Yesterday

Intraday-1.02%